News >

Deeper Understanding of NETs Biology May Hold Key to Therapeutic Advances

Jessica Hergert
Published: Thursday, Oct 31, 2019

Lakshmi N. Rajdev, MD

Lakshmi N. Rajdev, MD

As a greater understanding of the biological differences across neuroendocrine tumor (NET) subtypes is observed, other therapeutic strategies beyond somatostatin analogs are coming to the forefront, said Lakshmi N. Rajdev, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication